A detailed history of Xtx Topco LTD transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 23,862 shares of XLO stock, worth $26,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,862
Previous 33,289 28.32%
Holding current value
$26,964
Previous $31,000 41.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.73 - $1.02 $6,881 - $9,615
-9,427 Reduced 28.32%
23,862 $18,000
Q2 2024

Aug 12, 2024

BUY
$0.9 - $1.53 $29,960 - $50,932
33,289 New
33,289 $31,000

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $31M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.